By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Pharmalink AB 

Karlavägen 18

Stockholm    SE-102 49  Sweden
Phone: 46-0-8-505-66-312 Fax: 46-0-8-611-3303


SEARCH JOBS


Industry
Pharmaceutical






Company News
Pharmalink AB Elects Bengt Julander As Chairman 10/14/2014 8:32:40 AM
Pharmalink AB's Core Patents For Nefecon® Treatment For Renal Disease Granted In United States, Europe, China And Hong Kong 7/10/2014 9:49:12 AM
Pharmalink AB Strengthens its Board Of Directors 7/7/2014 10:58:08 AM
Pharmalink AB Receives US Orphan Drug Designation for Busulipo™, its Novel Oncology Product for Bone Marrow Transplantation 10/29/2013 10:24:04 AM
Pharmalink AB Snags $15 Million to Undertake Pivotal Studies With Lead Programs in Cancer Therapy and Renal Disease 10/4/2013 6:54:58 AM
Pharmalink AB Raises SEK 35 Million Through Share Issue 1/4/2012 10:05:08 AM
Pharmalink AB Gains Exclusive Licence to Archimedes Pharma's TARGIT(R) Technology for Nefecon(R) (PL-56) Program 12/13/2011 10:13:24 AM
Pharmalink AB Elects Anders Wiklund as Chairman and Appoints Elisabeth Lindner to its Board of Directors 11/14/2011 12:32:45 PM
Grifols Agrees to Acquire Intellectual Property for Treatment of Post-Polio Syndrome From Pharmalink AB 5/20/2010 9:41:47 AM
Pharmalink AB Receives Patent for Nefecon(R) Principle 10/26/2009 8:25:18 AM
12
//-->